Peptide-based influenza vaccine formulation

Details Peptide-based influenza vaccine formulation Peptide-based influenza vaccine formulation

A - Human Necessities

61

K

A61K 39/145 (2006.01) A61K 39/39 (2006.01) A61P 31/16 (2006.01)

Patent

CA 2610667

Peptide-based anti-influenza formulations against influenza A and B are disclosed. The peptides are derived from influenza-based epitopes. The formulations are based on peptide mixtures which may be formulated so that variability is present at particular residues. The formulations can be used to prepare vaccines for preventing influenza in human, avian, murine or equine animals.

L'invention concerne des formulations peptidiques de vaccin contre la grippe A et la grippe B. Les peptides de l'invention sont dérivés d'épitopes grippaux. Les formulations sont basées sur des mélanges peptidiques qui peuvent être formulés de sorte qu'une variabilité soit présente au niveau de résidus particuliers. Les formulations peuvent être utilisées pour préparer des vaccins destinés à prévenir la grippe chez l'être humain et chez les animaux aviaires, murins ou équins.

Affiliated with

Also associated with

Rating

Peptide-based influenza vaccine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-based influenza vaccine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-based influenza vaccine formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1868962